Dacarbazine

Especificaciones

4342-03-4Número CAS

224-396-1Número CE

4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamideNombre IUPAC

C6H10N6OFórmula química

182.18 g/molPeso molecular

dacarbazine; DTIC; DTIC-Dome; 4342-03-4; Deticene; Biocarbazine R; Decarbazine; ICDMT; ICDT; Dacarbazinum; NSC-45388; Imidazole carboxamide; Dacarbasine; Dicarbazine; 4-(Dimethyltriazeno)imidazole-5-carboxamide; NSC45388; 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide; NSC 45388; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; Di-me-triazenoimidazolecarboxamide; (Dimethyltriazeno)imidazolecarboxamide; 5-(Dimethyltriazeno)imidazole-4-carboxamide; dacarbazina; NCI-C04717; 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide; 7GR28W0FJI; 4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide; HSDB 3219; NCI C04717; 1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-; DTXCID20369; Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-; 4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide; DTXSID0020369; 5-(dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide; Dacatic; DTICDome; DTIC Dome; (5Z)-5-(dimethylaminohydrazono)imidazole-4-carboxamide; Dimethyl Triazeno Imidazole Carboxamide; Carboxamide, Dimethyl Imidazole; Imidazole Carboxamide, Dimethyl; CHEBI:4305; Dakarbazin; Asercit; Detimedac; Fauldetic; Dacarbazine-DTIC; Dacarbazina Almirall; 5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide; RefChem:57350; L01AX04; Imidazole Carboxamide Dimethyltriazeno; Dimethyl Triazeno Imidazol Carboxamide; dimethyl-triazeno-imidazole carboxamide; Dimethyl-triazeno-imidazole-carboximide; Dimethyl (triazeno) imidazolecarboxamide; WR-139007; 5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide; 224-396-1; Dimethyl Imidazole Carboxamide; Biocarbazine; DTIE; Dacarbazinum [INN-Latin]; Dacarbazino [INN-Spanish]; Dtic-Dome (TN); 4-[(1E)-3,3-Dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide; C6H10N6O; MFCD00057167; 4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide; NCGC00091861-01; 4-[(E)-dimethylaminoazo]-1H-imidazole-5-carboxamide; Dacarbazino; 5-(3,3-Dimethyl-1-triazen-1-yl)-1H-imidazole-4-carboxamide; CAS-4342-03-4; SR-05000001598; 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide; CCRIS 190; Dacarbazine (JAN/USP/INN); 5-(Dimethyltriazeno)imidazole-4-carboximide; (E)-Dacarbazine; Dimethyltriazenoimidazolecarboxamide; EINECS 224-396-1; 4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; Dacarbazine (Standard); 4(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide; AI3-52825; DACARBAZINE [MI]; DACARBAZINE [INN]; DACARBAZINE [JAN]; Dacarbazine (DTIC-Dome); DACARBAZINE [HSDB]; DACARBAZINE [IARC]; DACARBAZINE [USAN]; CHEMBL476; UNII-7GR28W0FJI; (5E)-5-(dimethylaminohydrazono)imidazole-4-carboxamide; 5- (3,3-Dimethyl-1-triazenyl) imidazole-4-carboxamide; DACARBAZINE [VANDF]; DACARBAZINE [MART.]; DACARBAZINE [USP-RS]; DACARBAZINE [WHO-DD]; DACARBAZINE [WHO-IP]; SPECTRUM1500218; Carboxamide, 5-(3,3-dimethyl-1-triazeno)imidazole-4-; CHEBI:94587; HMS501A08; HY-B0078R; DACARBAZINE [ORANGE BOOK]; Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-; CHEBI:177836; BDBM233149; DACARBAZINE [EP MONOGRAPH]; HMS2090A20; HMS2091I20; Pharmakon1600-01500218; DACARBAZINE [USP MONOGRAPH]; DACARBAZINUM [WHO-IP LATIN]; HY-B0078; Tox21_111171; Tox21_201010; CCG-35381; CCG-36068; CCG-40272; EBC-17029; EBC-24021; NSC759610; NSC799994; s1221; WLN: T5M CNJ DVZ ENUNN1&1; AKOS005220502; AKOS015850745; AKOS026750028; Tox21_111171_1; CS-1772; DB00851; KS-5186; NSC-759610; NSC-799994; Dacarbazine [USAN:USP:INN:BAN:JAN]; NCGC00091861-02; NCGC00091861-03; NCGC00091861-04; NCGC00091861-05; NCGC00091861-07; NCGC00091861-15; NCGC00188955-01; NCGC00258563-01; 94361-71-4; SBI-0051328.P003; ST51014976; C06936; Carboxamide,3-dimethyl-1-triazeno)imidazole-4-; D00288; EN300-7357020; Imidazole-4-carboxamide,3-dimethyl-1-triazeno)-; 5-[(dimethylamino)diazenyl]imidazole-4-carboxamide; F036541; SR-05000001598-1; SR-05000001598-3; 1H-Imidazole-4-carboxamide,3-dimethyl-1-triazenyl)-; BRD-K35520305-001-04-5; BRD-K35520305-001-07-8; BRD-K35520305-001-16-9; BRD-K35520305-001-17-7; Imidazole-4(or 5)-carboxamide,3-dimethyl-1-triazeno)-; Z2289761610; 5-(3,3-Dimethyltriaz-1-enyl)-1H-imidazole-4-carboxamide; Dacarbazine, British Pharmacopoeia (BP) Reference Standard; Dacarbazine, European Pharmacopoeia (EP) Reference Standard; 4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide; Dacarbazine, United States Pharmacopeia (USP) Reference Standard; Dacarbazine, Pharmaceutical Secondary Standard; Certified Reference MaterialSinónimos